DK0626853T3 - Anvendelse af substituerede adeninderivater til behandling af multipel sclerose - Google Patents
Anvendelse af substituerede adeninderivater til behandling af multipel scleroseInfo
- Publication number
- DK0626853T3 DK0626853T3 DK93906071T DK93906071T DK0626853T3 DK 0626853 T3 DK0626853 T3 DK 0626853T3 DK 93906071 T DK93906071 T DK 93906071T DK 93906071 T DK93906071 T DK 93906071T DK 0626853 T3 DK0626853 T3 DK 0626853T3
- Authority
- DK
- Denmark
- Prior art keywords
- multiple sclerosis
- treatment
- adenine derivatives
- substituted adenine
- formula
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/838,546 US5310732A (en) | 1986-02-03 | 1992-02-19 | 2-halo-2'-deoxyadenosines in the treatment of rheumatoid arthritis |
PCT/US1993/001467 WO1993016706A1 (en) | 1992-02-19 | 1993-02-18 | Use of substituted adenine derivatives for treating multiple sclerosis |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0626853T3 true DK0626853T3 (da) | 2000-08-07 |
Family
ID=25277387
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK93906071T DK0626853T3 (da) | 1992-02-19 | 1993-02-18 | Anvendelse af substituerede adeninderivater til behandling af multipel sclerose |
Country Status (15)
Country | Link |
---|---|
US (4) | US5310732A (da) |
EP (1) | EP0626853B1 (da) |
JP (1) | JP2688113B2 (da) |
AT (1) | ATE192045T1 (da) |
AU (1) | AU682818B2 (da) |
BR (1) | BR9305907A (da) |
CA (1) | CA2130275C (da) |
CH (1) | CH684310A5 (da) |
DE (1) | DE69328474T2 (da) |
DK (1) | DK0626853T3 (da) |
FI (1) | FI943805A (da) |
HU (1) | HU218656B (da) |
NO (2) | NO309025B1 (da) |
RU (1) | RU2130308C1 (da) |
WO (1) | WO1993016706A1 (da) |
Families Citing this family (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5310732A (en) * | 1986-02-03 | 1994-05-10 | The Scripps Research Institute | 2-halo-2'-deoxyadenosines in the treatment of rheumatoid arthritis |
US5624913A (en) * | 1991-04-05 | 1997-04-29 | Wisconsin Alumni Research Foundation | Method reducing TNF-alpha in mammals with cerebral malaria |
CA2136226C (en) * | 1992-05-19 | 2000-05-16 | Ernest Beutler | Use of 2-halo adenine derivatives as therapeutic agents against chronic myelogenous leukemia |
US5424296A (en) * | 1993-04-15 | 1995-06-13 | The Scripps Research Institute | 2-Halo-2'-deoxyadenosines as therapeutic agents against malignant astrocytoma |
US5672622A (en) * | 1994-04-21 | 1997-09-30 | Berlex Laboratories, Inc. | Treatment of multiple sclerosis |
US5773570A (en) * | 1994-05-20 | 1998-06-30 | The Regents Of The University Of California | Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
US7094597B1 (en) | 1994-05-20 | 2006-08-22 | The Regents Of The University Of California | Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
AU7470794A (en) * | 1994-05-26 | 1995-12-21 | Scripps Research Institute, The | 2-halo-2'-deoxyadenosine treatement for inflammatory bowel disease |
US6060501A (en) * | 1994-06-02 | 2000-05-09 | Schering Aktiengesellschaft | Combined treatment of multiple sclerosis |
US5817641A (en) * | 1994-07-21 | 1998-10-06 | Thomas Jefferson University | Treatment of enterotoxigenic diarrhea with 2-substituted adenosine derivatives |
US5510336A (en) * | 1994-09-06 | 1996-04-23 | Saven; Alan | 2-halo-2'-deoxyadenosine treatment for histiocytosis |
US5641757A (en) * | 1994-12-21 | 1997-06-24 | Ortho Pharmaceutical Corporation | Stable 2-chloro-2'-deoxyadenosine formulations |
AU762821B2 (en) * | 1994-12-22 | 2003-07-03 | Ortho-Mcneil Pharmaceutical, Inc. | 'Soluble 2-chloro-2'-deoxyadenosine formulations' |
JPH10512549A (ja) * | 1994-12-22 | 1998-12-02 | オーソ・フアーマシユーチカル・コーポレーシヨン | 可溶性の2−クロロ−2’−デオキシアデノシン配合物 |
JPH11500110A (ja) * | 1995-02-10 | 1999-01-06 | シエーリング アクチエンゲゼルシヤフト | Tnf−抑制用製剤 |
US5811073A (en) * | 1995-06-19 | 1998-09-22 | President And Fellows Of Harvard College | Method for radioisotopic detection and localization of inflammation in a host |
US6096310A (en) * | 1997-04-15 | 2000-08-01 | Bier; Milan | Oral immunotherapy of bacterial overgrowth |
US6617171B2 (en) | 1998-02-27 | 2003-09-09 | The General Hospital Corporation | Methods for diagnosing and treating autoimmune disease |
US6174873B1 (en) | 1998-11-04 | 2001-01-16 | Supergen, Inc. | Oral administration of adenosine analogs |
WO2001007054A1 (en) * | 1999-07-22 | 2001-02-01 | Supergen, Inc. | Methods for treating autoimmune diseases |
US6358939B1 (en) | 1999-12-21 | 2002-03-19 | Northern Lights Pharmaceuticals, Llc | Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease |
US6989377B2 (en) | 1999-12-21 | 2006-01-24 | Wisconsin Alumni Research Foundation | Treating vitamin D responsive diseases |
JP4555536B2 (ja) * | 2000-02-18 | 2010-10-06 | サザン・リサーチ・インスティテュート | 2−クロロ−9−(2−デオキシ−2−フルオロ−β−D−アラビノフラノシル)−9H−プリン−6−アミンの合成方法 |
US7608683B2 (en) * | 2000-08-09 | 2009-10-27 | The Regents Of The University Of California | Stress proteins and peptides and methods of use thereof |
US6989146B2 (en) * | 2000-08-09 | 2006-01-24 | The Regents Of The University Of California | Stress proteins and peptides and methods of use thereof |
BR0115246A (pt) | 2000-11-01 | 2005-04-26 | Univ California | Peptìdeos imunomoduladores derivados de proteìnas de choque e seu uso |
WO2002078446A1 (en) * | 2001-03-29 | 2002-10-10 | Bioenergy Inc. | Composition to reduce exercise-induced swelling of joints |
US7528247B2 (en) * | 2001-08-02 | 2009-05-05 | Genzyme Corporation | Process for preparing purine nucleosides |
US7368423B1 (en) * | 2001-12-05 | 2008-05-06 | The Scripps Research Institute | Composition and method for treating chronic allograft rejection |
US20060100167A1 (en) * | 2002-09-27 | 2006-05-11 | Wood Christopher B | Methods and compositions for the treatment of autoimmune disorders using clofarabine |
CA2500091A1 (en) * | 2002-09-27 | 2004-04-08 | Bioenvision, Inc. | Methods and compositions for the treatment of lupus using clofarabine |
US20080221029A1 (en) * | 2002-10-31 | 2008-09-11 | Regents Of The University Of Colorado | Methods for treatment of thiol-containing compound deficient conditions |
US7790762B2 (en) * | 2002-10-31 | 2010-09-07 | National Jewish Health | Compounds and methods for thiol-containing compound efflux and cancer treatment |
US20040087527A1 (en) * | 2002-10-31 | 2004-05-06 | Day Brian J. | Methods for treatment of thiol-containing compound deficient conditions |
GB0228723D0 (en) * | 2002-12-09 | 2003-01-15 | Cambridge Biotechnology Ltd | Treatment of pain |
GB0305153D0 (en) * | 2003-03-07 | 2003-04-09 | Cambridge Biotechnology Ltd | Identification of therapeutic compounds |
EP2272503B1 (en) | 2003-03-28 | 2013-03-20 | Ares Trading S.A. | Oral formulations of cladribine |
EA009714B1 (ru) * | 2003-03-28 | 2008-02-28 | Арес Трейдинг С.А. | Препараты кладрибина для улучшенной пероральной доставки и доставки через слизистые оболочки |
SG175450A1 (en) * | 2003-03-28 | 2011-11-28 | Ares Trading Sa | Oral formulations of cladribine |
EP1650192A4 (en) * | 2003-07-24 | 2007-03-21 | Astellas Pharma Inc | QUINOLONE DERIVATIVE OR SALT THEREOF |
US20070167353A1 (en) * | 2003-10-24 | 2007-07-19 | John Hilfinger | Prodrug composition |
ES2287804T3 (es) * | 2003-12-29 | 2007-12-16 | Can-Fite Biopharma Ltd. | Metodo para el tratamiento de esclerosis multiples. |
US20080089892A1 (en) | 2004-01-12 | 2008-04-17 | Eli Lilly And Co. | Fc Region Variants |
US20050277615A1 (en) * | 2004-05-17 | 2005-12-15 | Can-Fite Biopharma Ltd. | Pharmaceutical compositions having anti-inflammatory activity |
PT1835922E (pt) * | 2004-12-22 | 2009-07-08 | Merck Serono Sa | Tratamento combinado para esclerose múltipla |
EP1827461B1 (en) * | 2004-12-22 | 2012-02-29 | Merck Serono SA | Cladribine regimen for treating multiple sclerosis |
US8658622B2 (en) * | 2005-01-14 | 2014-02-25 | Regents Of The University Of California | Methods and compositions for preventing and treating a disease related to glycan dysregulation |
JP2009537605A (ja) | 2006-05-24 | 2009-10-29 | メルク セローノ ソシエテ アノニム | 多発性硬化症を治療するためのクラドリビン・レジメン |
US8126690B2 (en) * | 2007-05-18 | 2012-02-28 | The Regents Of The University Of Michigan | Algorithms to predict clinical response, adherence, and shunting with thiopurines |
EP2030615A3 (en) * | 2007-08-13 | 2009-12-02 | ELFORD, Howard L. | Ribonucleotide reductase inhibitors for use in the treatment or prevention of neuroinflammatory or autoimmune diseases |
US8845627B2 (en) | 2008-08-22 | 2014-09-30 | Boston Scientific Scimed, Inc. | Regulating pressure to lower temperature in a cryotherapy balloon catheter |
WO2010042933A2 (en) | 2008-10-10 | 2010-04-15 | Northwestern University | Inhibition and treatment of prostate cancer metastasis |
EP2343074A1 (en) | 2009-12-23 | 2011-07-13 | Merck Serono S.A. | Use of purine analogues for treating airway diseases |
WO2012022740A1 (en) | 2010-08-18 | 2012-02-23 | Merck Serono S.A. | Combination treatment of multiple sclerosis |
CN113512522A (zh) | 2013-03-15 | 2021-10-19 | 普林斯顿大学理事会 | 用于高通量纯化的方法和设备 |
US20150064153A1 (en) | 2013-03-15 | 2015-03-05 | The Trustees Of Princeton University | High efficiency microfluidic purification of stem cells to improve transplants |
CN105264127B (zh) | 2013-03-15 | 2019-04-09 | Gpb科学有限责任公司 | 颗粒的片上微流体处理 |
GB201401465D0 (en) | 2014-01-29 | 2014-03-12 | Roach Arthur H | Use of cladribine for treating autoimmune inflammatory disease |
EP3215149A4 (en) | 2014-11-06 | 2018-06-27 | Northwestern University | Inhibition of cancer cell motility |
AU2016311278B2 (en) * | 2015-08-24 | 2021-03-25 | Gpb Scientific, Inc. | Methods and devices for multi-step cell purification and concentration |
US10976232B2 (en) | 2015-08-24 | 2021-04-13 | Gpb Scientific, Inc. | Methods and devices for multi-step cell purification and concentration |
GB2564717A (en) | 2017-07-21 | 2019-01-23 | Chord Therapeutics S A R L | Use of cladribine for treating autoimmune neuromuscular disease |
MX2020005266A (es) | 2017-11-24 | 2020-09-18 | Merck Patent Gmbh | Regimen de cladribina para usarse en el tratamiento de formas progresivas de esclerosis multiple. |
BR112023003432A2 (pt) | 2020-09-10 | 2023-03-21 | Merck Patent Gmbh | Regime de tratamento para o tratamento de doenças autoimunes |
GB2601786A (en) | 2020-12-10 | 2022-06-15 | Chord Therapeutics S A R L | Use of cladribine for treating immune brain disease |
EP4302091A1 (en) | 2021-03-03 | 2024-01-10 | Ares Trading S.A. | Improved treatment methods using dmds for the treatment of autoimmune diseases, and biomarker for predicting and/or optimising said treatment methods |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1572069C3 (de) * | 1966-03-12 | 1976-01-08 | Hoechst Ag, 6000 Frankfurt | Lichtempfindliche Schicht zur Herstellung von Druckformen |
US3472838A (en) * | 1967-12-01 | 1969-10-14 | Parke Davis & Co | 9 - (beta - d - arabinofuranosyl) - 6 - (amidino) purine compounds and methods for their production |
US4826823A (en) * | 1985-02-05 | 1989-05-02 | Warner-Lambert Company | Methods of using 2-chloro-2'-deoxyadenosine-5'-phosphate and its salts |
US4751221A (en) * | 1985-10-18 | 1988-06-14 | Sloan-Kettering Institute For Cancer Research | 2-fluoro-arabinofuranosyl purine nucleosides |
US5310732A (en) * | 1986-02-03 | 1994-05-10 | The Scripps Research Institute | 2-halo-2'-deoxyadenosines in the treatment of rheumatoid arthritis |
US5106837A (en) * | 1988-03-16 | 1992-04-21 | The Scripps Research Institute | Adenosine derivatives with therapeutic activity |
GB8708050D0 (en) * | 1987-04-03 | 1987-05-07 | Wellcome Found | Therapeutic nucleosides |
GB8725466D0 (en) | 1987-10-30 | 1987-12-02 | Hoffmann La Roche | Purine derivatives |
NZ226672A (en) * | 1987-10-30 | 1991-07-26 | Hoffmann La Roche | 6-amino-9-(2,3-dideoxy-2-fluoro-b-d-threopentofuranosyl)-9h-purine derivatives and pharmaceutical compositions |
US4968702A (en) * | 1989-01-17 | 1990-11-06 | American Cyanamid Company | Substituted quinolinecarboxylic acids |
-
1992
- 1992-02-19 US US07/838,546 patent/US5310732A/en not_active Expired - Lifetime
-
1993
- 1993-02-18 AU AU37249/93A patent/AU682818B2/en not_active Expired
- 1993-02-18 WO PCT/US1993/001467 patent/WO1993016706A1/en active IP Right Grant
- 1993-02-18 US US08/256,931 patent/US5506214A/en not_active Expired - Lifetime
- 1993-02-18 JP JP5514960A patent/JP2688113B2/ja not_active Expired - Lifetime
- 1993-02-18 DK DK93906071T patent/DK0626853T3/da active
- 1993-02-18 EP EP93906071A patent/EP0626853B1/en not_active Expired - Lifetime
- 1993-02-18 BR BR9305907A patent/BR9305907A/pt not_active Application Discontinuation
- 1993-02-18 DE DE69328474T patent/DE69328474T2/de not_active Expired - Lifetime
- 1993-02-18 CH CH3143/93A patent/CH684310A5/de not_active IP Right Cessation
- 1993-02-18 HU HU9402392A patent/HU218656B/hu unknown
- 1993-02-18 CA CA002130275A patent/CA2130275C/en not_active Expired - Lifetime
- 1993-02-18 AT AT93906071T patent/ATE192045T1/de not_active IP Right Cessation
- 1993-02-18 RU RU94038043A patent/RU2130308C1/ru active
-
1994
- 1994-04-26 US US08/233,056 patent/US5541164A/en not_active Expired - Lifetime
- 1994-05-19 US US08/246,328 patent/US5506213A/en not_active Expired - Lifetime
- 1994-07-25 NO NO942765A patent/NO309025B1/no not_active IP Right Cessation
- 1994-08-18 FI FI943805A patent/FI943805A/fi not_active Application Discontinuation
-
2000
- 2000-02-16 NO NO20000762A patent/NO322328B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2130275A1 (en) | 1993-09-02 |
US5506213A (en) | 1996-04-09 |
HU218656B (hu) | 2000-10-28 |
NO322328B1 (no) | 2006-09-18 |
WO1993016706A1 (en) | 1993-09-02 |
NO309025B1 (no) | 2000-12-04 |
NO942765L (no) | 1994-09-13 |
FI943805A (fi) | 1994-10-19 |
NO20000762L (no) | 1994-09-13 |
AU3724993A (en) | 1993-09-13 |
RU94038043A (ru) | 1996-11-20 |
US5541164A (en) | 1996-07-30 |
BR9305907A (pt) | 1997-10-21 |
US5310732A (en) | 1994-05-10 |
EP0626853B1 (en) | 2000-04-26 |
FI943805A0 (fi) | 1994-08-18 |
NO942765D0 (no) | 1994-07-25 |
US5506214A (en) | 1996-04-09 |
HU9402392D0 (en) | 1994-10-28 |
EP0626853A1 (en) | 1994-12-07 |
CH684310A5 (de) | 1994-08-31 |
DE69328474D1 (de) | 2000-05-31 |
AU682818B2 (en) | 1997-10-23 |
RU2130308C1 (ru) | 1999-05-20 |
CA2130275C (en) | 1999-06-29 |
JP2688113B2 (ja) | 1997-12-08 |
DE69328474T2 (de) | 2000-09-28 |
NO20000762D0 (no) | 2000-02-16 |
ATE192045T1 (de) | 2000-05-15 |
HUT68030A (en) | 1995-05-29 |
JPH07507540A (ja) | 1995-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0626853T3 (da) | Anvendelse af substituerede adeninderivater til behandling af multipel sclerose | |
DE69333109D1 (de) | Therapeutische nukleoside | |
DK0922045T3 (da) | Bicykliske pyrimidinderivater og deres anvendelse som antikoagulanter | |
DE69109125T2 (de) | Ringverknüpfte analoge von stickstoffenthaltenden nichtaromatischen heterocyclen. | |
ES2067314T3 (es) | 3-benzacepin-zonas sustituidas por un grupo benzociclobutilo o indanil-alquil-amino-alquilo, utiles en el tratamiento de las afecciones cardiovasculares. | |
DK0687176T3 (da) | Anvendelse af riluzol til behandling af AIDS-relaterede nervesygdomme | |
FI895447A0 (fi) | Substituerade adeninderivat anvaendbara som terapeutiska substanser. | |
DK0565631T3 (da) | Antivirale forbindelser | |
DK0710239T3 (da) | Nye 9-N-bicycliske nucleosidmidler anvendelige som selektive inhibitorer af proinflammatoriske cytokiner | |
ES2139669T3 (es) | Nuevos derivados triciclicos de indan-2-mercaptoacetilamida 2-substituidos utiles como inhibidores de la encefalinasa. | |
FI900083A (fi) | Nya tetralinderivat. | |
ES8201964A1 (es) | Procedimiento de preparar derivados sulfonato | |
DE69418050T2 (de) | Antivirale analoge von difluorostaton | |
ES2087813A1 (es) | Heterociclos no-aromaticos que contienen nitrogeno bencilamino substituidos. |